Imaging Cardiac Amyloidosis: Patient Page | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: Education

Scientific literature and patient education texts

Back to Education / Patient Education

Imaging Cardiac Amyloidosis: Patient Page

key information

source: Journal of Nuclear Cardiology

year: 2019

authors: Sharmila Dorbala, Rodney Falk

summary/abstract:

Amyloidosis is a disease that develops when abnormally folded proteins collect together to form amyloid fibrils, which deposit in various organs and cause organ damage. Amyloidosis in the heart can be identified by using various imaging tests. This patient page provides an overview of imaging in cardiac amyloidosis.

Cardiac amyloidosis is caused by the deposition of amyloid fibrils between the heart muscle cells. The two most common types of protein fibrils depositing in the heart are light chain (AL) and transthyretin (ATTR) proteins. While light chain amyloidosis results from an excess of abnormal light chain proteins produced by cancerous plasma cells in the bone marrow, transthyretin amyloidosis may result from misfolding healthy TTR proteins produced by the liver, as in wild type amyloidosis of aging. Alternatively, a genetic mutation of the TTR gene can result in altered TTR protein that aggregates and causes hereditary ATTR amyloidosis. Whatever the cause, a build-up of amyloid fibrils in the heart may keep the heart muscle from relaxing between heartbeats, causing high pressure in the heart chambers and blood vessels. Eventually, the heart may not be able to squeeze blood adequately to supply oxygen to the body.

organization: Brigham and Women's Hospital, USA; Harvard Medical School, USA

DOI: 10.1007/s12350-018-01551-5

read more

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close